Antidiabetic effect of kolaviron, a biflavonoid complex isolated from Garcinia kola seeds, in Wistar rats

African Health Sciences

Volumn 12, Issue 4, 2012, Pages 498-506

  Adaramoye, Oluwatosin A ^a  

^a UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Antidiabetic; Kolaviron; Protection; Streptozotocin; Tissues

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; AMYLASE; BILIRUBIN; CREATINE KINASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLIBENCLAMIDE; GLUCOSE; HEMOGLOBIN A1C; KOLAVIRON; LACTATE DEHYDROGENASE; UREA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIDIABETIC ACTIVITY; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY WEIGHT; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC CARDIOMYOPATHY; DIABETIC NEPHROPATHY; DRUG EFFECT; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GARCINIA KOLA; GLUCOSE BLOOD LEVEL; GLUCOSE URINE LEVEL; HEART PROTECTION; HEMOGLOBIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; LIVER DISEASE; LIVER PROTECTION; LIVER WEIGHT; MALE; NONHUMAN; PLANT SEED; PROTEIN URINE LEVEL; RAT; RENAL PROTECTION; UREA BLOOD LEVEL;

ANTIDIABETIC; KOLAVIRON; PROTECTION; STREPTOZOTOCIN; TISSUES;

ANIMALS; BIFLAVONOIDS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FLAVONOIDS; GARCINIA KOLA; HYPOGLYCEMIC AGENTS; LIVER; MALE; ORGAN SIZE; PHYTOTHERAPY; PLANT EXTRACTS; RATS; RATS, WISTAR; SEEDS;

EID: 84873259385     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i4.16     Document Type: Article

References (38)

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-1431.
2. Nissen SE, Wolski K. Effects of rosiglitazone on the risk of myocardial infarction and death from cardiovascular cause. N Engl J Med 2007; 356: 2457-2471.
3. Adeneye AA, Agbaje EO. Pharmacological evaluation of oral hypoglycaemic and antidiabetic effects of fresh leaves ethanol extract of Morinda lucida Benth. in normal and alloxan-induced diabetic rats. Afr J Biomed Res 2008; 11: 65-71.
4. Vaya J, Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation. Free Radic Biol Med 1997; 23: 302-13.
5. Iwu MM, Igboko OA. Flavonoids of Garcinia kola seeds. J. Nat Prod. 1982; 45: 650-651.
6. Cotterhill PJ, Scheinmann F, Stenhouse TA. Extractives from Guttiferae: kolaflavanone, a new biflavanone from the nuts of Garcinia kola Heckel. J Chem Soc Perkin Trans 1978; 1: 246.
7. Iwu MM, Igboko OA, Onwuchekwa U, Okunji CO. Evaluation of the anti-hepatotoxicity of the biflavonoids of Garcinia kola seeds. J Ethnopharmacol 1987; 21: 127-38.
8. Adaramoye OA, Adeyemi EO. Hepatoprotection of D-galactosamine-induced toxicity in mice by purified fractions from Garcinia kola seed. Basic Clin Pharmacol Toxicol 2006a; 98: 135-141.
9. Adaramoye OA, Nwaneri VO, Anyanwu KC, Farombi EO, Emerole GO. Possible anti-atherogenic effect of kolaviron (A Garcinia kola seed extract) in hypercholesterolemic rats. Clin Exp Pharmacol Physiol 2005a; 32: 40-46.
10. Adaramoye OA, Farombi EO, Adeyemi EO, Emerole GO. Inhibition of human low-density lipoprotein oxidation by flavonoids of Garcinia kola seeds. Pak J Med Sci 2005b; 21: 331-339.
11. Iwu MM, Igboko OA, Okunji CO, Tempesta MS. Anti-diabetic and aldose reductase activities of biflavanones of Garcinia kola. J Pharm Pharmacol 1990; 42: 290-292.
12. National Institutes of Health (US). Guide for the Care and Use of Laboratory Animals. NIH Publication No. 85-23. Revised 1985.
13. Sharma SR, Dwivedi SK, Swarup D. Hypoglycemic, antihyperglycemic and hypolipidemic activities of Caesalpinia bonducella seeds in rats. J Ethnopharmacol 1997; 58: 39-44.
14. Nakhoda A, Wong HA. The induction of diabetes in rats by intramuscular administration of streptozotocin. Experientia 1979; 35: 1679-1680.
15. Farswan M, Mazumder PM, Percha V. Protective effect of Cassia glauca Linn. on the serum glucose and hepatic enzymes level in streptozotocin induced NIDDM in rats. Indian J Pharmacol 2009; 41: 19-22.
16. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
17. Mohun AF, Cook LJ. Simple method for measuring serum level of glutamate-oxaloacetate and glutamate-pyruvate transaminases in laboratories. J Clin Pathol 1957; 10: 394-399.
18. Reitman S, Frankel S. A colorimetric method for the determination of serum level of glutamate-oxaloacetate and pyruvate transaminases. Am J Clin Pathol 1957; 28: 56-63.
19. Jaffe M. Ueber den Neiderschlag, welchen Pikrinsäure im normalen harn Erzeught und über eine neue Reaction des Kreatinins. Z Physiol Chem 1886; 10: 391-400.
20. Talke H, Schubert GE. Enzymatische Harnstoff bestimmung in Blut and serum in Optischen Test nach Warburg. Klin Wochschr 1965; 43:174.
21. Rutkowski RB, Debaare L. An ultra-micro colorimetric method for determination of total and direct serum bilirubin. Clin Chem 1966; 12: 432-438.
22. Fossati R, Melzid'Eril G V, Turenghi G, Precipe L, Berti G. A kinetic colorimetric assay of gamma-glutamyltransferase. Clin Chem 1986; 32: 1581-1584.
23. Gella FJ, Gubern G, Vidal R, Canalias F. Determination of total and pancreatic alpha-amylase in human serum with 2-chloro-4-nitrophenyl-alpha-D-maltotrioside as substrate. Clin Chim Acta 1997; 259: 147-160.
24. Zimmerman HJ, Weinstein BS. Lactic dehydrogenase activity in human serum. J Lab & Clin Med 1956; 48: 607-609.
25. Hirokawa K, Shimoji K, Kajiyama N. An enzymatic method for the determination of hemoglobin A1C. Biotechnol Lett 2005; 27: 963-968.
26. Williamson T. A comparison between the phosphastrate and phenyl phosphate methods of alkaline phosphatase assay. Med Lab Technol 1972; 29: 182-187.
27. Aybar MJ, Sánchez Riera AN, Grau A, Sánchez SS. Hypoglycemic effects of water extract of Smallanthus soncifolius (yacan) leaves in normal and diabetic rats. J Ethanopharmacol 2001; 74: 125-132.
28. Hayden MR, Tyagi SC. Intimal redox stress: accelerated atherosclerosis in metabolic syndrome and type 2 diabetes mellitus. Atheroscleropathy Cardiovasc Diabetol 2002; 1: 3-8.
29. Wiernsperger NF. Oxidative stress as a therapeutic target in diabetes: revisiting the controversy. Diabetes Metab 2003; 29: 579-585.
30. Ghacha R, Sinha AK, Karkar AM. HbA1c and serum fructosamine as marker of chronic glycemic state in type 2 diabetic hemodialysis patients. Dialysis Transplant 2001; 30: 214-217.
31. Fuji E, Nomoto T. Changes in glycosylated hemoglobin in short and semi long term streptozotocin-diabetic mice and rats. Japan J Pharmacol 1984; 34: 113-115.
32. UKPDS group. Intensive blood glucose control with sulphonylurea or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet 1998; 352: 837-853.
33. Aldrich JE. Clinical enzymology. In: Anderson SC, Cockayne S, eds. Clinical Chemistry: Concept and Applications. New York: McGraw Hill, 2003: 261-284.
34. Zhao X, Bassirat M, Zeinab K, Helme RD. Effects of diabetes on creatine kinase activity in streptozotocin-diabetic rats. Chin Med J (Engl) 1999; 112: 1028-1031.
35. Al-Shabanah AO, El-Kashef HA, Badary OA, Al-Bekairi AM, Elmazar MM. Effect of streptozotocin-induced hyperglycemia on intravenous pharmacokinetics and acute cardiotoxicity of doxorubicin in rats. Pharmacol Res 2000; 41: 31-37.
36. Limidi JK, Hyde GM. Evaluation of abnormal liver function tests. Postgrad Med J 2003; 79: 307-312.
37. Yousef WM, Omar AH, Ghanayem NM. Effect of some calcium channel blockers in experimentally induced diabetic nephropathy in rats. Int J Diabetes Metab 2006; 14: 39-49.
38. Farombi EO, Shrotriya S, Surh YJ. Kolaviron inhibits dimethyl nitrosamine-induced liver injury by suppressing COX-2 and iNOS expression via NF-kappaB and AP-1. Life Sci 2009; 84: 149-155.